X4 PHARMACEUTICALS, INC
Profile
Company Names
X4 PHARMACEUTICALS, INC
ARSANIS, INC.
Addresses
61 NORTH BEACON STREET, 4TH FLOOR, BOSTON, MA 02134
890 WINTER STREET, SUITE 230, WALTHAM, MA 02451
890 WINTER STREET, SUITE 230, WALTHAM, MA 02451
7 LUCENT DRIVE, LEBANON, NH 03766
16 CAVENDISH COURT, LEBANON, NH 03766
Phone Numbers
857-529-8300
781-819-5704
603-727-7107
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2010
State Incorporated:
DELAWARE
Total Amount Raised:
$320,311,984.00
Number of Funding Rounds:
10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2025-08-13
$84,999,985.00
$84,999,985.00
$0.00
Equity
9
2023-05-18
$65,015,462.00
$65,023,725.00
$8,263.00
Equity
8
2022-07-06
$55,749,999.00
$111,526,550.00
$55,776,551.00
Equity
7
2017-11-20
$20,000,000.00
$20,000,000.00
$0.00
Equity
6
2017-04-24
$45,539,314.00
$50,539,341.00
$5,000,027.00
Equity
5
2016-04-12
$15,007,220.00
$15,007,220.00
$0.00
Equity, Debt
4
2015-12-16
$4,000,000.00
$4,000,000.00
$0.00
Debt
3
2013-07-30
$20,000,000.00
$20,000,000.00
$0.00
Equity
2
2011-01-31
$9,600,002.00
$9,600,002.00
$0.00
Equity
1
2010-09-15
$400,002.00
$400,002.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
WILLIAM
ALISKI
DIRECTOR
ERRIK
B.
ANDERSON
EXECUTIVE OFFICER, DIRECTOR
DANIEL
BURGESS
DIRECTOR
WILLIAM
CLARK
DIRECTOR
BRAZIL POTASH CORP.
| DELTEK, INC
| GENOCEA BIOSCIENCES, INC.
| MICROANGEL FUND I LLC
| MICROANGEL STARTUP FUND I LLC
| MICROANGEL FUND V LLC
| MICROANGEL FUND II LLC
| MICROANGEL FUND III LLC
| MICROANGEL INCUBATOR FUND I LLC
| MICROANGEL SMASH FUND I LLC
| MICROVENTURE MARKETPLACE INC.
| MICROANGEL STARTUP FUND VIII
| MICROANGEL EM FUND I
| MICROANGEL GRAPHICLY FUND I LLC
| MV STARTUP FUND I LLC SERIES 3
| SPINDLE, INC.
| MV VC FUND II, LLC
| DIAMOND KINETICS, INC.
| MV LIQUIDITY FUND XXIV LLC
| MV LIQUIDITY FUND XXV LLC
| MV STARTUP FUND XXIII LLC
| MV VENTURE FUND VI LLC
| MV STARTUP FUND XXIV LLC
| MV STARTUP FUND XXVI LLC
| SPARTAN FUND I LLC
| MV VC FUND VI LLC
| MV LIQUIDITY FUND XXIX LLC
| SAVI TECHNOLOGY, INC.
| MV LIQUIDITY FUND XXXII LLC
| MV VENTURE FUND VIII LLC
| MV STARTUP FUND XXIX LLC
| MV STARTUP FUND XXX LLC
| MV VC FUND VIII LLC
| MV VC FUND V LLC
| MV LIQUIDITY FUND XXVIII LLC
| JOYBOX STUDIOS, INC.
| WEESCHOOL, INC.
| ARSANIS, INC.
| GREY, INC.
| ROOBRIK, INC.
| JAW VENTURES, LLC
| ROMAN 413 INC.
| PARAMETRIX GROUP HOLDINGS, INC.
| IBIO, INC.
| UMA VENTURES SPV 0 LP
| UMA VENTURES I LP
| PIXION BATTERIES INC.
| DROVER VENTURES FUND I, LLC
TILLMAN
GERNGROSS
EXECUTIVE OFFICER, DIRECTOR
TILLMAN
U.
GERNGROSS
EXECUTIVE OFFICER, DIRECTOR
CARL
GORDON
DIRECTOR
FARALLON BIOSCIENCES, INC
| AMNIS CORP
| IGENICA INC
| ACCELERON PHARMA INC
| ARAGON PHARMACEUTICALS, INC.
| GOOD START GENETICS, INC.
| ARSANIS, INC.
| SINGULEX INC
| SELECTA BIOSCIENCES INC
| IGENICA BIOTHERAPEUTICS, INC
| COMPASS THERAPEUTICS LLC
| ADICET BIO, INC.
| INTELLIA THERAPEUTICS, INC.
| ALECTOR LLC
| GEMINI THERAPEUTICS, INC.
| SPRINGWORKS THERAPEUTICS, LLC
| PREVAIL THERAPEUTICS INC.
| THESEUS PHARMACEUTICALS, INC.
| TP THERAPEUTICS, INC.
| KUMQUAT BIOSCIENCES INC
| PASSAGE BIO, INC.
| KEROS THERAPEUTICS, INC.
| ADARX PHARMACEUTICALS, INC.
| BLOSSOMHILL THERAPEUTICS, INC.
| SCRIBE THERAPEUTICS, INC.
| GARUDA THERAPEUTICS, INC.
| ODYSSEY THERAPEUTICS, INC.
| ALTEROME THERAPEUTICS, INC.
| AVENZO THERAPEUTICS, INC.
| MBX BIOSCIENCES, INC.
| ARRIVENT BIOPHARMA, INC.
| BELENOS BIOSCIENCES, INC.
| LOMOND THERAPEUTICS HOLDINGS, INC.
| STAR THERAPEUTICS LLC
MICHAEL
GRAY
EXECUTIVE OFFICER
CORE FIXED INCOME SER OF THE HARTFOR INSTL TRUST
| TREASURY INFLATION PROTECTED SECURITIES (TIPS) SERIES OF THE HARTFORD INSTITUTIONAL TRUST
| CORE PLUS FIXED INCOME SERIES OF THE HARTFORD INSTITUTIONAL TRUST
| CORE PLUS UNIVERSAL SERIES
| IVANHOE MINES LTD.
| IKASYSTEMS CORP
| ARSANIS, INC.
| 3AXISDATA LLC
| SIGMASENSE, LLC
| HIGHGOLD MINING INC.
| TRITON DEBT OPPORTUNITIES FUND II SCSP
| TORO SILVER CORP.
| ADYTON RESOURCES CORP
ALISON
LAWTON
DIRECTOR
TERRANCE
MCGUIRE
DIRECTOR
MICROCHIPS, INC.
| ARSENAL MEDICAL, INC.
| ADIMAB, INC.
| ARSANIS, INC.
| ARSENAL VASCULAR, INC.
| ARSENAL MEDICAL, INC.
| ADIMAB, LLC
| 480 BIOMEDICAL, INC.
| POLARIS ENTREPRENEURS- FUND VII, L.P.
| PULMATRIX OPERATING COMPANY, INC.
| PULMATRIX, INC.
| ICELANDIC PROVISIONS, INC.
| SEER BIOSCIENCES, INC.
| CYCLERION THERAPEUTICS, INC.
| ANKYRA THERAPEUTICS, INC.
| ADAGIO THERAPEUTICS, INC.
| FARADAY PHARMACEUTICALS, INC.
| TECTONIC THERAPEUTIC, INC.
ADAM
MOSTAFA
EXECUTIVE OFFICER
CLAUDIO
NESSI
DIRECTOR
PAULA
RAGAN
EXECUTIVE OFFICER, DIRECTOR
MICHAEL
ROSS
DIRECTOR
CERVILENZ INC
| JUVARIS BIO THERAPEUTICS INC
| IKANO THERAPEUTICS INC.
| ADIMAB, INC.
| SV LIFE SCIENCES FUND V LP
| LINK MEDICINE CORP
| CATABASIS PHARMACEUTICALS INC
| SV LIFE SCIENCES FUND V STRATEGIC PARTNERS, L.P.
| ARSANIS, INC.
| BALANCE HEALTH CORP
| ABCAM PLC
| ADIMAB, LLC
| AVITIDE, INC.
| OPHTHOTECH CORP.
| THESAN PHARMACEUTICALS, INC.
| SV LIFE SCIENCES FUND VI, L.P.
| DECIPHERA PHARMACEUTICALS, LLC
| DEMENTIA DISCOVERY LP
| AMERICLEAN HOLDINGS LLC
| SV LIFE SCIENCES FUND VI STRATEGIC PARTNERS, L.P.
| FRESCO FOODS, INC.
| SUTRO BIOPHARMA INC
| RIBOMETRIX, INC.
| JASON RYAN
| NICE RECOVERY SYSTEMS LLC
| THERINI BIO, INC.
| MAINE CRISP COMPANY, LLC
| JOSEPH VENTURES ALLIUM I LLC, SERIES A
| XILIO THERAPEUTICS, INC.
| JOSEPH VENTURES ALLIUM I LLC, SERIES C
| SV LIFE SCIENCES FUND IV CF, L.P.
| ANDOVIA INC.
| TREX HOLDINGS INC.
| DUALITAS THERAPEUTICS, INC.
RENE
RUSSO
EXECUTIVE OFFICER, DIRECTOR
AMY
SCHULMAN
DIRECTOR
ARSANIS, INC.
| SUONO BIO, INC.
| QUENTIS THERAPEUTICS, INC.
| GLYMPSE BIO, INC.
| CYCLERION THERAPEUTICS, INC.
| CARDURION PHARMACEUTICALS, INC.
| FRACTYL LABORATORIES INC.
| AMAGMA, INC.
| BYHEART, INC.
| QURALIS CORP
| FRACTYL HEALTH, INC.
| LYNDRA THERAPEUTICS, INC.
| THIRTY MADISON, INC.
| VOLASTRA THERAPEUTICS, INC.
| POLARIS PARTNERS X, L.P.
| SEQUELAE, INC.
| NOETIK INC.
MICHAEL
WYZGA
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2025-08-13
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2023-05-18
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2022-07-06
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2017-11-20
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

